44 related articles for article (PubMed ID: 28816531)
1. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
2. Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism.
Rowlands C; Zyada A; Zouwail S; Joshi H; Stechman MJ; Scott-Coombes DM
Ann R Coll Surg Engl; 2013 Oct; 95(7):523-8. PubMed ID: 24112502
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of the risk of urolithiasis following parathyroidectomy in patients with primary hyperparathyroidism.
Wang X; Shi G; Li G; Tang G
Int Urol Nephrol; 2024 Apr; 56(4):1217-1225. PubMed ID: 38038823
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism.
Yankova I; Lilova L; Petrova D; Dimitrova I; Stoynova M; Shinkov A; Kovatcheva R
Endocrine; 2024 Mar; ():. PubMed ID: 38489132
[TBL] [Abstract][Full Text] [Related]
5. Risk of Gallstone Disease in Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.
Pal R; Banerjee M; Prasad TN; Kumar A; Bhadada T; Vyas A; Mukhopadhyay S; Bhadada SK
Endocr Pract; 2024 Mar; 30(3):225-230. PubMed ID: 38086526
[TBL] [Abstract][Full Text] [Related]
6. Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study.
Cipriani C; Carnevale V; Biamonte F; Piemonte S; Pepe J; Nieddu L; Bilezikian JP; Minisola S
Eur J Endocrinol; 2014 Oct; 171(4):481-7. PubMed ID: 25015979
[TBL] [Abstract][Full Text] [Related]
7. The Ca∗Cl/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism.
Yu Y; Qiu J; Chuan F; Feng Z; Long J; Zhou B
Endocr Pract; 2024 Mar; 30(3):231-238. PubMed ID: 38086525
[TBL] [Abstract][Full Text] [Related]
8. Emerging pattern of asymptomatic hyperparathyroidism in South India - a six-year retrospective study.
Viswanathan G; Mathew V; Jeeragi M; George B; Bantwal G; Ayyar V; Michael J
Folia Med (Plovdiv); 2024 Apr; 66(2):221-226. PubMed ID: 38690817
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Recurrent Urolithiasis in Iran: Findings from a Nationwide Study.
Basiri A; Kashi AH; Zahir M; Borumandnia N; Taheri M; Golshan S; Narouie B; Mombeini H
Arch Iran Med; 2024 Apr; 27(4):200-205. PubMed ID: 38685846
[TBL] [Abstract][Full Text] [Related]
10. Variable presentation and outcomes of primary hyperparathyroidism in children and adolescents.
Das D; Banerjee M; Kar A; Bhattacharyya R; Chowdhury S; Mukhopadhyay S
J Pediatr Endocrinol Metab; 2024 May; ():. PubMed ID: 38706116
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Transfer Learning for Effective Urolithiasis Detection.
Choi HS; Kim JS; Whangbo TK; Kim KH
Int Neurourol J; 2024 Feb; 28(Suppl 1):62. PubMed ID: 38461858
[No Abstract] [Full Text] [Related]
12. Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism.
Zhou Y; Chu X; Jiang D; Wu X; Xu J; Qi H; Tang Y; Dai Y
Front Endocrinol (Lausanne); 2022; 13():947497. PubMed ID: 36120445
[TBL] [Abstract][Full Text] [Related]
13. [The clinical practice guidelines for primary hyperparathyroidism, short version].
Mokrysheva NG; Eremkina AK; Mirnaya SS; Krupinova JA; Voronkova IA; Kim IV; Beltsevich DG; Kuznetzov NS; Pigarova EA; Rozhinskaya LY; Degtyarev MV; Egshatyan LV; Rumiantsev PA; Andreeva EN; Аntsiferov MB; Markina NV; Kryukova IV; Karonova TL; Lukyanov SV; Sleptcov IV; Chagai NB; Melnichenko GA; Dedov II
Probl Endokrinol (Mosk); 2021 Aug; 67(4):94-124. PubMed ID: 34533017
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones.
Ganesan C; Weia B; Thomas IC; Song S; Velaer K; Seib CD; Conti S; Elliott C; Chertow GM; Kurella Tamura M; Leppert JT; Pao AC
JAMA Surg; 2020 Sep; 155(9):861-868. PubMed ID: 32725208
[TBL] [Abstract][Full Text] [Related]
15. PREVALENCE AND PREDICTORS OF PRIMARY HYPERPARATHYROIDISM AMONG PATIENTS WITH UROLITHIASIS.
Sharma S; Rastogi A; Bhadada SK; Singh P; Varshney S; Behera A; Bhansali A; Singh SK; Rao SD
Endocr Pract; 2017 Nov; 23(11):1311-1315. PubMed ID: 28816531
[TBL] [Abstract][Full Text] [Related]
16. Primary hyperparathyroidism in Taiwan: clinical features and prevalence in a single-center experience.
Chen HH; Chen YW; Wu CJ
Endocrine; 2010 Apr; 37(2):373-8. PubMed ID: 20960277
[TBL] [Abstract][Full Text] [Related]
17. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.
Lemos ALP; Andrade SRL; Pontes LLH; Teixeira PMC; Bandeira E; Bandeira LC; Bandeira F
Kidney Blood Press Res; 2019; 44(5):1189-1195. PubMed ID: 31542783
[TBL] [Abstract][Full Text] [Related]
18. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
[TBL] [Abstract][Full Text] [Related]
19. The association of primary hyperparathyroidism with pancreatitis.
Bai HX; Giefer M; Patel M; Orabi AI; Husain SZ
J Clin Gastroenterol; 2012 Sep; 46(8):656-61. PubMed ID: 22874807
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
